Live Breaking News & Updates on Hakim Bouterfa

Stay updated with breaking news from Hakim bouterfa. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

EQS-News: First CNS Lymphoma Patient Dosed in Phase I/II PTT101 Study with Yttrium (90Y) Anditixafortide (PentixaTher)

EQS-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Study First CNS Lymphoma Patient Dosed in Phas. ....

Hakim Bouterfa , Eckert Ziegler Strahlen , Karolin Riehle , Eckert Ziegler , University Hospital In Essen , University Hospital , Clinicaltrials Gov , Chief Medical Officer ,

First CNS Lymphoma Patient Dosed in Phase I/II PTT101 Study with Yttrium (90Y) Anditixafortide (Pent

EQS-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): StudyFirst CNS Lymphoma Patient Dosed in Phase I/II PTT101 Study with Yttrium (90Y) Anditixafortide (PentixaTher) 22.11.2023 / 16:02 CET/CESTThe issuer is solely responsible for the content of this announcement.Berlin/Würzburg, 22 November 202. ....

Eckert Ziegler , Hakim Bouterfa , Eckert Ziegler Strahlen , Karolin Riehle , Y Anditixafortide Pentixather , University Hospital In Essen , Distribution Services , Patient Dosed , University Hospital , Clinicaltrials Gov , Chief Medical Officer , Corporate News , Regulatory Announcements ,

First CNS Lymphoma Patient Dosed in Phase I/II PTT101 Study with Yttrium (90Y) Anditixafortide (PentixaTher)

EQS-News: Eckert & Ziegler Strahlen- und Medizintechnik AG

/ Key word: Study

First CNS Lymphoma Patient Dosed in Phase I/II PTT101 Study with Yttrium Anditixafortide . ....

Eckert Ziegler , Eckert Ziegler Strahlen , Hakim Bouterfa , Karolin Riehle , University Hospital In Essen , University Hospital , Clinicaltrials Gov , Chief Medical Officer ,

Chairman of the Supervisory Board of Eckert & Ziegler moves to subsidiary Pentixapharm

The company founder and Chairman of the Supervisory Board of the radiation and medical technology specialist Eckert & Ziegler is moving from the parent company to the spin-off subsidiary for clinical. ....

Andreas Eckert , Eckert Ziegler , Hakim Bouterfa , Group Executive Board , Supervisory Board , Executive Board ,

Ckert & Ziegler: Annual General Meeting Approves Dividend of EUR 0.50 per Share. Reorganization of the Executive Board, Supervisory Board and Group Executive Committee.

EQS-News: Eckert & Ziegler Strahlen- und Medizintechnik AG

/ Key word: AGM/EGM/Personnel

ckert & Ziegler: Annual General Meeting Approves Dividend of EUR 0.50 per Share.. | June 7, 2023 ....

United States , Karolin Riehle , Hakim Bouterfa , Harald Hasselmann , Wolfgang Maennig , Eckert Ziegler , Andreas Eckert , Eckert Ziegler Strahlen , Lutz Helmke , Frank Yeager , Jutta Ludwig , Annual General Meeting , Executive Board , Supervisory Board , Annual General , Executive Committee , Ana Ramirez , General Manager , Isotope Products , Latin American , Eckert Ziegler Strahlen Und Medizintechnik Ag Stock Exchange , Press Release , Er Euz De0005659700 ,